Abhijeet Pandey
Overview
Explore the profile of Abhijeet Pandey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shreya A, Pandey A, Kulkarni S, Bhaskar K, Parekh H, Mutalik S
Sci Rep
. 2024 Nov;
14(1):28225.
PMID: 39548220
Asenapine maleate (ASPM) is a second-generation atypical antipsychotic that is approved for treating acute schizophrenia and bipolar disorder in adults by the US FDA. The major downside of ASPM therapy...
2.
Kulkarni S, Kumar A, Pandey A, Soman S, Subramanian S, Mutalik S
ACS Omega
. 2024 Oct;
9(41):42410-42422.
PMID: 39431106
Lactoferrin, an iron binding glycoprotein-based nanoparticle, has emerged as a promising platform for drug delivery and imaging. This study presents the potential use of the protein nanocarrier in tracking sentinel...
3.
Gupta A, Kulkarni S, Soman S, Saha M, Kulkarni J, Rana K, et al.
Int J Pharm
. 2024 Sep;
665:124687.
PMID: 39265846
Cancer is a significant worldwide health concern, and there is a demand for ongoing breakthroughs in treatment techniques. Microspheres are among the most studied drug delivery platforms for delivering cargo...
4.
Kulkarni S, Pandey A, Soman S, Nannuri S, Kumar A, Bhavsar D, et al.
Int J Biol Macromol
. 2024 Aug;
278(Pt 1):134381.
PMID: 39127292
Zirconium-based metal-organic frameworks (UiO-66) have gained considerable attention owing to their versatile application. In the present research, UiO-66 was synthesized via a defect engineering approach, and its toxicity profile was...
5.
Nikam A, Roy A, Raychaudhuri R, Navti P, Soman S, Kulkarni S, et al.
Curr Pharm Des
. 2024 May;
30(7):489-518.
PMID: 38757691
Topical drug delivery holds immense significance in dermatological treatments due to its non-invasive nature and direct application to the target site. Organogels, a promising class of topical drug delivery systems,...
6.
Kulkarni S, Soman S, Navti P, Roy A, Nikam A, Vineeth P, et al.
Materials (Basel)
. 2024 Mar;
17(6).
PMID: 38541577
MXenes are two-dimensional transition metal carbides, nitrides, and carbonitrides that have become important materials in nanotechnology because of their remarkable mechanical, electrical, and thermal characteristics. This review emphasizes how crucial...
7.
Maremanda V, Maertin D, Bitar M, Pandey A
AAPS PharmSciTech
. 2024 Feb;
25(3):50.
PMID: 38424241
The advancement in the formulation and characterization techniques have paved the path for development of new as well as modification of existing dosage forms. The present work explores the role...
8.
Kumar A, Kulkarni S, Pandey A, Mutalik S, Subramanian S
Nanomedicine (Lond)
. 2024 Jan;
19(1):59-77.
PMID: 38197375
Sentinel lymph node (SLN) detection and biopsy is a critical staging component for several cancers. Apart from established methods using dyes or radiolabeled colloids, newer techniques are emerging, like near-infrared...
9.
Padya B, Fernandes G, Hegde S, Kulkarni S, Pandey A, Deshpande P, et al.
Pharmaceutics
. 2023 Nov;
15(11).
PMID: 38004573
The therapeutic effectiveness of the most widely used anticancer drug 5-fluorouracil (5-FU) is constrained by its high metabolism, short half-life, and rapid drug resistance after chemotherapy. Although various nanodrug delivery...
10.
Nikam A, Jacob A, Raychaudhuri R, Fernandes G, Pandey A, Rao V, et al.
Pharmaceutics
. 2023 Sep;
15(9).
PMID: 37765146
5-Fluorouracil (5-FU), a BCS class III drug, has low oral bioavailability and is cytotoxic in nature causing severe systemic side effects when administered through the intravenous route. Topical drug delivery...